Emcure Pharmaceuticals Ltd. - Research Center

---

Results

• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

180.85

180.85

180.85

180.85

180.85

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

1,661.02

1,531.68

2,120.92

1,733.70

1,596.66

Loan funds

Secured loans

1,667.76

1,573.79

1,305.57

1,014.80

985.66

Unsecured loans

-

-

-

-

-

Total

3,509.63

3,286.32

3,607.34

2,929.35

2,763.17

Uses of funds

Fixed assets

Gross block

2,317.73

2,054.78

1,903.54

1,673.27

1,489.98

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

885.03

747.42

625.64

507.21

390.05

Net block

1,432.71

1,307.36

1,277.90

1,166.06

1,099.92

Capital work-in-progress

253.10

239.25

192.09

326.06

405.96

Investments

690.02

563.36

863.73

407.71

310.57

Net current assets

Current assets, loans & advances

2,240.03

2,213.21

2,529.47

1,971.38

1,761.12

Less : current liabilities & provisions

1,106.22

1,036.86

1,255.86

941.85

814.40

Total net current assets

1,133.81

1,176.35

1,273.62

1,029.53

946.72

Miscellaneous expenses not written

-

-

-

-

-

Total

3,509.63

3,286.32

3,607.34

2,929.35

2,763.17

Notes:

Book value of unquoted investments

690.02

563.36

863.73

407.71

310.57

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

66.56

89.11

45.52

52.35

-

Number of equity sharesoutstanding (Lacs)

1808.52

1808.52

1808.52

1808.52

1808.52